Biotechs And Tech Lead The Way For 2016 – Yahoo Finance

Encouraging recent news was also unveiled for Amarantus Bioscience (AMBS) , a biotech working on specially formulated biologics for Parkinson’s. The company received a notice of allowance for a U.S. patent application to enhance IP protection for eltoprazine, the company’s leading candidate for treating elodea-induced dyskinesia in Parkinson’s patients. LabStyle Innovations (DRIO) also has enjoyed a recent upswing from buzz over its flagship product, the Dario Blood Glucose Monitoring System. This system allows diabetics to monitor their blood glucose levels via their smart phone devices, while also providing tracking and treatment tools through website and phone applications. This data can be viewed by the patient’s doctors or family members to enhance care and treatment. Using a multi-pronged revenue approach via sales of the application, glucose strips, and other software services, LabStyle forecasts as a stock to watch thanks to so much upside from revenue potential and uniqueness of brand. As the New Year approaches, small cap biotech stocks have emerged as a prime candidate for investors looking to catch small cap stocks with the potential for huge upside. Cannabis Bioscience in particular has demonstrated a willingness to participate in acquisitions and diversification that could trigger company growth for years to come. Seraphim Strategies is a third party publisher. Not a registered broker/dealer/analyst/adviser, holds no investment licenses and may not sell, offer to sell or offer to buy any security.

To read more visit

Share This Post

Recent Articles

Leave a Reply

© 2018 Medical Marijuana Stocks. All rights reserved. Site Admin · Entries RSS · Comments RSS
Powered by WordPress · Designed by Theme Junkie